Arca
Skip to content

Sunburn

Drug research and approvals for sunburn: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 17, 2026, 0 studies of sunburn are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 0
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Drug Pipeline

12 approved, 2 in phase 3, 4 in phase 2, 1 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this condition

Approved: Titanium dioxide, Lidocaine, Zinc oxide, Diphenhydramine, Dibucaine, Menthol, Pramoxine, Benzocaine, Dimethicone, Salicylic acid, Octinoxate, Avobenzone

Dexchlorpheniramine
Phase 3 Histamine H1 receptor antagonist
Diclofenac
Phase 3 Cyclooxygenase inhibitor
Ibuprofen
Phase 2 Cyclooxygenase inhibitor
Chlorpheniramine
Phase 2 Histamine H1 receptor antagonist
Petrolatum
Phase 2
Melatonin
Phase 1 Melatonin receptor agonist

How Its Trials Ended

23 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong
  • Completed, result not reported1252%
  • Status unknown522%
  • Ongoing313%
  • Met its primary endpoint14%
  • Stopped: sponsor or business decision14%
  • Stopped: other or unclear14%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.